4.4 Letter

RE: I Think It's Been Met With a Shrug: Oncologists' Views Toward and Experiences With Right-to-Try Response

Related references

Note: Only part of the references are listed.
Article Oncology

I Think It's Been Met With a Shrug: Oncologists' Views Toward and Experiences With Right-to-Try

Cambray Smith et al.

Summary: Most oncologists have limited familiarity with the federal Right-to-Try (RTT) Act, and some are confused about the legislation. While interested in decreased regulatory burdens, concerns were raised about safety, oversight, structure, data collection, and potential patient expectations. Few oncologists have discussed or attempted to obtain drugs through RTT, leading to questions about its practicality and suggestions for alternative ways to improve access.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Letter Oncology

RE: I Think It's Been Met With a Shrug: Oncologists' Views Toward and Experiences With Right-to-Try

Andrea Martani et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Article Oncology

Ethical concerns regarding private equity in Right to Try in the USA

Susannah W Lee et al.

LANCET ONCOLOGY (2020)

Article Public, Environmental & Occupational Health

Purposeful SDM: A problem-based approach to caring for patients with shared decision making

Ian G. Hargraves et al.

PATIENT EDUCATION AND COUNSELING (2019)

Article Health Care Sciences & Services

Shared Decision Making: The Need For Patient-Clinician Conversation, Not Just Information

Ian Hargraves et al.

HEALTH AFFAIRS (2016)

Article Medicine, General & Internal

End-of-life conversations - Evolving practice and theory

DG Larson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)